NMD4C at Ottawa NMD 2023
This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023), with a program emphasizing recent breakthroughs in basic and translational research and clinical discoveries in neuromuscular disease. As a network, we had the opportunity to present three posters on the outcomes of select network activities from the first NMD4C grant period. Read the NMD4C abstracts here. All of the Ottawa NMD abstracts are also available on the event website. We also hosted a booth at the conference to share information on the network, recruit new members, and discuss our work with the many investigators and neuromuscular stakeholders who visited!
NMD4C Posters at Ottawa NMD 2023
- Compliance to Duchenne Muscular Dystrophy Care Considerations in Canada
- Expert Patient Capacity Building in Neuromuscular Disease Research
- The Neuromuscular Disease Network for Canada (NMD4C): An interdisciplinary national collaboration to tackle unmet needs for NMD research and care
Read the NMD4C abstracts here.
NMD4C Investigators that Presented at Ottawa NMD 2023
The three-day Ottawa NMD 2023 conference hosted nationally and internationally renowned basic researchers and clinicians to present talks highlighting advances in all aspects of NMD research, including new clinical diagnostic techniques, biology of disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat NMDs. Several network investigators delivered talks across the action-packed three-day program.
- Dr Craig Campbell: Duchenne Muscular Dystrophy Episignature
- Dr Natasha Chang: Muscle stem cell dysfunction in Duchenne muscular dystrophy
- Dr Gerald Pfeffer: Transcriptomic profiles and pathologic correlation in adult-onset myopathies
- Dr Hernan Gonorazky: MRI in the age of Artificial Intelligence
- Dr Mireille Khacho: Impact of Mitochondrial Dynamics on Muscle Stem Cell Function: Insights from Physiology, Diseases and Ageing
- Dr Hanns Lochmüller: Congenital myasthenic syndromes – diagnosis and therapy
- Dr Rami Massie: Update in autoimmune neuropathies
- Dr Hugh McMillan: Gene therapy in spinal muscular atrophy
- Dr Kerri Schellenberg: Clinical Updates in Spinal Bulbar Muscular Atrophy
- Dr Jodi Warman Chardon: Muscle Imaging in Genetic and Autoimmune Muscle Diseases
- Dr Nicolas Dumont: Clearance of defective muscle stem cells by senolytics reduces the expression of senescence associated secretory phenotype and restores myogenesis in myotonic dystrophy type 1
- Stacey Lintern / Dr Homira Osman: Opening remarks at Keynote Session
We are looking forward to Ottawa NMD 2025!
Read next...
You Can Now Find NMD4C on Bluesky
We’re moving to Bluesky! The NMD4C will now share updates on Bluesky instead of X. Please consider following us at @nmd4c.ca to stay connected!
CIHR Funds Interdisciplinary Project to Study SBMA in Indigenous Peoples of the Prairie Provinces
The NMD4C is excited to share that network investigators have been awarded funding from the CIHR for an Interdisciplinary Spinal-bulbar muscular atrophy study in Indigenous peoples of the prairie provinces, addressing the community needs, and developing clinical knowledge and therapies.
NMD4C Presents the 2025 Early Career Award Recipients
We are excited to announce the recipients of the 2025 NMD4C Early Career Awards! This is the third year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.
Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy
Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.
New Content Available in LEARNMD
LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!
Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group
We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C